'Recall ready': FDA urges companies to comply with drug recall guidance
The FDA has finalized guidance to help companies quickly recall products and take the necessary steps before a product reaches the recall stage, as part of work pull violative products and keep them out of the hands of consumers.
Initiation of Voluntary Recalls offers guidance for companies to develop procedures including training, planning and record-keeping to reduce the time a dangerous product is on the market and limit the risk of exposure. The FDA can recall controlled substances, biological products, human cells, tissues and cellular and tissue-based products, as well as medical devices and food.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.